| Application no. and date | 18725258.0 (espacenet) (Federated) (European Patent Register), 20180525 | | Patent/reg. no. and date | DK/EP 3630112, 20240131 | | Publication date | 20200408 | | Priority no. and date | EP 17174169, 20170602 | | EP pub. no. and date |
EP 3630112 20200408 | | Effective date | | | Applicant/owner | Bayer HealthCare LLC, 100 Bayer Boulevard
Whippany, NJ 07981, US | | Applicant ref. no. | 1686426 | | Inventor | ZOPF, Dieter, Neuwerker Weg 15a
14167 Berlin, DE,
RÖSE, Lars, Fuchsring 82
13465 Berlin, DE,
KIESSLING, Fabian, Weisshausstrasse 33
52066 Aachen, DE,
HOFF, Sabine, Brunnenallee 11a
14478 Postdam, DE,
LEDERLE, Wiltrud, Höhenweg 42
52074 Aachen, DE,
DOLESCHEL, Dennis, Leenheerstraat 31
6291JH Vaals, NL | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/395 (2006.01) , A61K 31/44 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATION AF REGORAFENIB OG NIVOLUMAB TIL BEHANDLING AF CANCER | | Int. application no. | EP2018063785 | | Int. publication no. | WO2018219807 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
